Coherus Biosciences | CHRS - Денежные средства и эквиваленты

Биржевая цена
1.75
Изменение за день
0.04 2.05%
Ежемесячно
5.12%
Ежегодный
79.05%
Q2 прогноз
1.63




Денежные средства и эквиваленты Изменить Дата
AbbVie USD 5.23B 400M 2025-12
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Akebia Therapeutics USD 184.84M 18.4M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Fujifilm JPY 160.88B 906M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xencor USD 54.07M 25.78M 2025-12
Zoetis USD 2.08B 649M 2025-09